Want to see JP:4881 full AI Analyst Report?

FunPep Company Limited (4881) Price & Analysis

0 Followers

4881 Stock Chart & Stats

¥79.00

¥1.00(0.72%)

At close: Jan 08 4:00 PM EST

¥79.00

¥1.00(0.72%)

Day’s Range― - ―

52-Week Range¥57.00 - ¥130.00

Previous CloseN/A

Volume532.20K

Average Volume (3M)245.82K

Market Cap

¥3.34B

Enterprise Value¥869.01M

Total Cash (Recent Filing)¥1.87B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)―

Beta1.01

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-39.76

Shares Outstanding50,666,700

10 Day Avg. Volume262,310

30 Day Avg. Volume245,823

Financial Highlights & Ratios

PEG Ratio-0.03

Price to Book (P/B)2.13

Price to Sales (P/S)9943.96

P/FCF Ratio-2.25

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-19.9

Revenue Forecast (FY)¥300.00M

Bulls Say, Bears Say

Bulls Say

Clean Balance SheetThe absence of debt materially reduces refinancing and interest-service risk, giving management structural flexibility to prioritize R&D or clinical milestones without near-term covenant pressure. Over the next 2–6 months this preserves optionality for fundraising or strategic partnerships.

Past Cash-flow ImprovementPrior improvements in free cash flow demonstrate the company has managed to reduce cash intensity in certain periods, indicating operational levers or execution ability exist. This history supports the view that management can potentially re-tighten spending or improve efficiency over a multi-month horizon.

Prior Revenue Uptick (2024)Revenue growth in 2024 shows the business can generate topline traction under the right conditions, reflecting product or clinical progress and commercial capability. That underlying revenue-generation capacity is a durable positive if the company stabilizes operations or re-enters growth trajectories.

Bears Say

Severe Revenue CollapseA ~94% revenue collapse critically weakens the business model by destroying operating leverage and recurring revenue foundations. Over months this reduces ability to sustain fixed R&D and G&A costs, undermines partner negotiations, and makes recovery more difficult without new product or contract wins.

Accelerating Cash BurnOperating cash flow deterioration indicates a faster depletion of liquidity and a shorter runway absent external financing. Structurally this elevates the probability of dilutive capital raises or asset sales in the 2–6 month window, constraining long-term investment in pipelines or commercialization.

Equity Erosion / Funding RiskSignificant equity erosion reflects cumulative losses and reduces the balance-sheet buffer to absorb future shortfalls. This structural weakening makes the company more reliant on external capital, raising dilution and refinancing risk and limiting strategic optionality over the medium term.

4881 FAQ

What was FunPep Company Limited’s price range in the past 12 months?

FunPep Company Limited lowest stock price was ¥57.00 and its highest was ¥130.00 in the past 12 months.

What is FunPep Company Limited’s market cap?

FunPep Company Limited’s market cap is ¥3.34B.

When is FunPep Company Limited’s upcoming earnings report date?

FunPep Company Limited’s upcoming earnings report date is Aug 14, 2026 which is in 26 days.

How were FunPep Company Limited’s earnings last quarter?

FunPep Company Limited released its earnings results on May 12, 2026. The company reported -¥7.03 earnings per share for the quarter, missing the consensus estimate of N/A by -¥7.03.

Is FunPep Company Limited overvalued?

According to Wall Street analysts FunPep Company Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does FunPep Company Limited pay dividends?

FunPep Company Limited does not currently pay dividends.

What is FunPep Company Limited’s EPS estimate?

FunPep Company Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does FunPep Company Limited have?

FunPep Company Limited has 50,666,700 shares outstanding.

What happened to FunPep Company Limited’s price movement after its last earnings report?

FunPep Company Limited reported an EPS of -¥7.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.429%.

Which hedge fund is a major shareholder of FunPep Company Limited?

Currently, no hedge funds are holding shares in JP:4881

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

FunPep Company Limited

FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.